|
HNRNPF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89230000002816E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62234999999677E-05 |
| Normal-vs-Stage2 |
1.752650E-04 |
| Normal-vs-Stage3 |
6.06199999975132E-07 |
| Normal-vs-Stage4 |
4.27229999999668E-05 |
| Stage1-vs-Stage2 |
3.676400E-01 |
| Stage1-vs-Stage3 |
3.340300E-02 |
| Stage1-vs-Stage4 |
2.690000E-01 |
| Stage2-vs-Stage3 |
4.699000E-01 |
| Stage2-vs-Stage4 |
9.593800E-01 |
| Stage3-vs-Stage4 |
4.507600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95699999983034E-07 |
| Normal-vs-AfricanAmerican |
3.68840000000148E-05 |
| Normal-vs-Asian |
9.802600E-01 |
| Caucasian-vs-AfricanAmerican |
3.600600E-01 |
| Caucasian-vs-Asian |
3.290600E-01 |
| AfricanAmerican-vs-Asian |
2.569800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53759999072167E-09 |
| Normal-vs-Female |
1.084680E-03 |
| Male-vs-Female |
3.418100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.295920E-02 |
| Normal-vs-Age(41-60Yrs) |
7.66039999988699E-07 |
| Normal-vs-Age(61-80Yrs) |
1.5318999999625E-06 |
| Normal-vs-Age(81-100Yrs) |
1.804660E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.750800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.053200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.574600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.407000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.548600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.449800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.848600E-01 |
| Normal-vs-Grade 2 |
1.008200E-04 |
| Normal-vs-Grade 3 |
5.29199994936391E-09 |
| Normal-vs-Grade 4 |
7.83960000000361E-05 |
| Grade 1-vs-Grade 2 |
2.971400E-01 |
| Grade 1-vs-Grade 3 |
4.194400E-02 |
| Grade 1-vs-Grade 4 |
1.470580E-01 |
| Grade 2-vs-Grade 3 |
8.217600E-03 |
| Grade 2-vs-Grade 4 |
1.479620E-01 |
| Grade 3-vs-Grade 4 |
9.242600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.376900E-04 |
| Normal-vs-ccB subtype |
1.1544000000363E-07 |
| ccA subtype-vs-ccB subtype |
8.623100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.24129999968493E-07 |
| Normal-vs-N1 |
1.161430E-01 |
| N0-vs-N1 |
4.784000E-01 |
|
|
